Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Divestments: 2019-2023

Historic Divestments for Lifecore Biomedical (LFCR) over the last 3 years, with May 2023 value amounting to $16.7 million.

  • Lifecore Biomedical's Divestments fell 96.46% to $1.0 million in Q2 2023 from the same period last year, while for May 2023 it was $45.1 million, marking a year-over-year change of. This contributed to the annual value of $16.7 million for FY2023, which is 77.32% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Divestments of $16.7 million as of FY2023, which was down 77.32% from $73.5 million recorded in FY2022.
  • In the past 5 years, Lifecore Biomedical's Divestments registered a high of $73.5 million during FY2022, and its lowest value of $7.0 million during FY2019.
  • For the 2-year period, Lifecore Biomedical's Divestments averaged around $45.1 million, with its median value being $45.1 million (2022).
  • Data for Lifecore Biomedical's Divestments shows a maximum YoY crashed of 77.32% (in 2023) over the last 5 years.
  • Lifecore Biomedical's Divestments (Yearly) stood at $7.0 million in 2019, then reached $73.5 million in 2022, then plummeted by 77.32% to $16.7 million in 2023.